Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial.
Naparat SukkriangSupawan BuranapinPublished in: Journal of diabetes investigation (2024)
Either IF 16:8 or 14:10 had a benefit in the percentage weight change, glucose and lipid profiles in obese diabetic patients compared with the control group when consumed for 3 days a week for 3 months.
Keyphrases
- weight loss
- end stage renal disease
- weight gain
- metabolic syndrome
- insulin resistance
- body mass index
- type diabetes
- chronic kidney disease
- bariatric surgery
- blood glucose
- physical activity
- ejection fraction
- newly diagnosed
- adipose tissue
- prognostic factors
- glycemic control
- patient reported outcomes
- obese patients
- skeletal muscle
- study protocol
- placebo controlled